Financials

  • Market Capitalization 16.8 M
  • Employee 1
  • Founded 2018
  • CEO N/A
  • Website www.cyclerion.com
  • Headquarter Massachusetts, United States
  • FIGI BBG00KXXHYD9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.14
Relación precio/flujo de caja
1.95

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4677
JSPR
Jasper Therapeutics, Inc. - Class A Common Stock
0.61 USD+5.17%+32.61%+35.56%-82.57%17.08 M USD
4678
PTN
Palatin Technologies, Inc. Common Stock
9.52 USD-4.80%-16.49%-32.05%+31.31%16.94 M USD
4682
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.34 USD-15.00%+9.68%-10.53%-73.85%16.52 M USD
4685
KTTA
Pasithea Therapeutics Corp. - Common Stock
0.49 USD0.00%-5.77%-15.52%-28.99%16.37 M USD

Noticias